April 2024
1. ZAMECNIK CR, Sowa GM, Abdelhak A, Dandekar R, et al
   An autoantibody signature predictive for multiple sclerosis.
   Nat Med. 2024 Apr 19. doi: 10.1038/s41591-024-02938.
   

   >> Share

   
   
2. ARNOLD C
   'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to celiac disease.
   Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
   

   >> Share

   
   July 2023
3. CARVALHO T
   Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis.
   Nat Med. 2023 Jul 5. doi: 10.1038/d41591-023-00060.
   

   >> Share

   
   January 2023
4. FOSSATI V, Peruzzotti-Jametti L, Pluchino S
   A neural stem-cell treatment for progressive multiple sclerosis.
   Nat Med. 2023 Jan 13. doi: 10.1038/s41591-022-02164.
   

   >> Share

   
   
5. GENCHI A, Brambilla E, Sangalli F, Radaelli M, et al
   Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
   Nat Med. 2023 Jan 9. doi: 10.1038/s41591-022-02097.
   

   >> Share

   
   December 2022
6. O'LEARY K
   Mounting evidence for EBV links to multiple sclerosis.
   Nat Med. 2022;28:2450.
   

   >> Share

   
   May 2022
7. BAR-OR A, Banwell B, Berger JR, Lieberman PM, et al
   Guilty by association: Epstein-Barr virus in multiple sclerosis.
   Nat Med. 2022 May 10. pii: 10.1038/s41591-022-01823.
   

   >> Share

   
   September 2021
8. APOSTOLIDIS SA, Kakara M, Painter MM, Goel RR, et al
   Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
   Nat Med. 2021 Sep 14. pii: 10.1038/s41591-021-01507.
   

   >> Share

   
   February 2021
9. STOWER H
   A functioning vaccine in mouse models of multiple sclerosis.
   Nat Med. 2021 Feb 1. pii: 10.1038/d41591-021-00006.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share